17-21 September 2018 at Wolfson College, University of Oxford, UK
There is increasing interest in the neglected subject of poor quality medicines/medical products, their epidemiology, origins, detection and impact and how to intervene to reduce their frequency. Poor quality medicines especially affect vulnerable populations in financially poor countries and although access to medicines has rightly been highlighted, access to good quality medicines has not. The course aims: To bring together a diversity of faculty and those interested in the subject (from public health, pharmacy, biomedical, chemist and law etc. backgrounds, including undergraduate/postgraduate students) to learn and discuss together. As the field is a young one both groups will benefit from this discussion.